GOLDMAN SACHS GROUP INC - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 79 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2015. The put-call ratio across all filers is 4.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$6,945,000
+18.5%
61,404
+4.9%
0.00%0.0%
Q1 2017$5,863,000
+2.0%
58,559
+9.5%
0.00%0.0%
Q4 2016$5,749,000
-67.0%
53,468
-61.8%
0.00%
-60.0%
Q3 2016$17,435,000
+340.1%
140,066
+275.9%
0.01%
+400.0%
Q2 2016$3,962,000
+53.5%
37,262
+65.3%
0.00%0.0%
Q1 2016$2,581,000
+56.1%
22,540
+94.2%
0.00%0.0%
Q4 2015$1,653,000
+137.8%
11,605
+92.3%
0.00%
Q2 2015$695,000
+20.5%
6,035
-0.1%
0.00%
Q1 2015$577,0006,0440.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Ariose Capital Management Ltd 88,655$10,149,0009.57%
WARBURG PINCUS LLC 4,087,200$467,903,0008.91%
RUDMAN ERROL M 64,001$7,327,0004.96%
INDUS CAPITAL PARTNERS, LLC 378,518$43,333,0004.22%
OBERWEIS ASSET MANAGEMENT INC/ 90,105$10,315,0002.98%
Ativo Capital Management LLC 85,623$9,802,0002.66%
Sensato Investors LLC 113,296$12,970,0002.31%
Cormorant Asset Management, LP 111,500$12,765,0001.92%
BARING ASSET MANAGEMENT Ltd 128,784$14,743,0001.23%
Visium Asset Management, LP 484,619$55,479,0000.94%
View complete list of CHINA BIOLOGIC PRODS INC shareholders